ArticleFrontiers in neurology2025
Innovative nomogram for predictive risk stratification of aspiration pneumonia in post-stroke dysphagia patients.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Construction and Application of a Quantitative Assessment Model for Swallowing Function Based on Cross-task Fusion and Temporal Context Aggregation Module.Journal of imaging informatics in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Post-stroke dysphagia (PSD) affects up to 76% of stroke patients and increases aspiration pneumonia (AP) risk, leading to higher mortality among older survivors. Current risk assessment tools for AP in PSD patients lack precision. Methods: We conducted a retrospective study of 7,134 stroke patients admitted to Jinshan Hospital from 2019 to 2023. We used multivariable logistic regression to identify AP predictors and constructed a nomogram model using these predictors. Model performance was evaluated using bootstrap resampling, calibration, and decision curve analysis. Internal validation was conducted on 30% of cases, and external validation was performed on 500 PSD patients from community health centers. Results: Among 2,663 PSD patients, 578 (21.7%) developed AP. Independent predictors included age, stroke severity, hyperlipidemia, hyperhomocysteinemia, heart failure, CRP, WBC, neutrophil ratio, Hb, FBG, prealbumin, BNP, and serum sodium. The nomogram model showed excellent discrimination (C-index: 0.885) and good agreement between predicted and observed AP probabilities. It provided net benefit across various threshold probabilities. Conclusion: Our study developed the first dedicated nomogram for AP risk prediction in PSD patients, incorporating novel predictor combinations and demonstrating robust validation across multi-center cohorts. This fills an important clinical need under community conditions by enabling early identification of high-risk PSD patients using routinely available clinical variables.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.